XENA®

XENA® is a blood-based liquid biopsy test for the early detection of ovarian cancer.

1 in 78 Women might develop ovarian cancer in their lifetime.

INEX's Solution

XENA® is a blood-based liquid biopsy test for the early detection of ovarian cancer.

NON-INVASIVE

XENA® only requires whole blood collected from the arm.

PERFORMANCE

Greatly enhanced accuracy over the current CA125 screening test.

INFORMED CLINICAL DECISIONS

Reduces the need for unnecessary invasive biopsies.

XENA® is under development and aimed to be launched in 2023.

INTERESTED?

If you're interested in XENA® and would like to know more or partner with us, let's chat.